Electrical stimulation zaps premature ejaculation

0

It is a problem for 25-40% of adult men, affecting up to 80 million men in the United States and Europe alone. Some 15 million of them are actively seeking treatment.

No, it’s not Covid. We are talking about premature ejaculation.

Today, there is no consistent or easy cure, only prescription creams and sprays that numb the genital area or antidepressants that delay ejaculation.

But both of these approaches can result in a loss of sensitivity, a trade-off that won’t appeal to everyone, says David Salton, CEO of the Hod HaSharon-based startup. medical virility.

Virility claims to have developed the first non-pharmacological, non-numbing technology to solve this highly private problem.

Virility’s high-tech disposable patch attaches with adhesive to the perineum, the area between the scrotum and the anus. The flexible patch adapts to the wearer’s body.

When turned on (pun intended), the patch delivers an electrical stimulus to muscles in the area, inhibiting rhythmic contractions leading to orgasm.

David Salton, CEO of Virility Medical. Photo courtesy of Virility Medical

According to Salton, the company’s research shows that a potency “vPatch” can extend ejaculation time by a factor of three and a half.

How much is such a benefit worth? At least $15 per intimate session, according to studies Virility has conducted on how much men would be willing to pay.

Accordingly, this is also the offered price of a single disposable vPatch. The product will be sold in boxes of two or four patches.

Clearly, and unsurprisingly here, sex sells.

Push button activated

The vPatch can be affixed anytime, including a few hours before, so it doesn’t require an awkward break in the middle of the action.

The man wearing the device (or his partner) simply presses a button on the patch to activate it.

The vPatch is meant to be discreet – a man’s partner might not even know he’s wearing it.

Salton explains in more detail how the vPatch works. “When you want to hold and not peak, you contract the pelvic muscles. The mind controls the whole process, but with external manipulation we can help contract the muscles,” he says.

The device is available in two intensities – low and high. The two-pack will have one of each so users can decide which suits them best.

Does the higher intensity version delay ejaculation longer?

Tal Gollan, founder and CTO of Virility Medical. Photo courtesy of Virility Medical

“There is no correlation with time,” says Tal Gollan, who founded the company and is now its technical director. “It’s just a question of comfort.”

Most users describe the vPatch as generating a slight tingle or tickle that is even pleasant.

There are no side effects, like with creams and SSRIs, which can cause headaches, nausea, erectile dysfunction and decreased libido. There are also no safety concerns, which is why the vPatch has received FDA and CE approvals.

Virility had a booth at the CES 2022 show in Las Vegas in January. “We had some interesting visitors from the big chains,” Salton told ISRAEL21c.

TENS

Virility did not invent the idea of ​​a transcutaneous electrical nerve stimulation (TENS) medical device. This technique has been used commercially for many years to provide temporary pain relief by sending small electrical pulses to the affected area.

This gave Virility a head start, as TENS has already been shown to be safe. Virility is the first company to apply TENS to the treatment of premature ejaculation.

Gollan got the idea for the vPatch after reading about a Turkish neurologist who used Botox to induce muscle paralysis as a way to treat premature ejaculation.

“I thought it could be done in a much simpler way than injecting Botox. This particular muscle is close to the surface of the skin, so it can be electrically stimulated,” Gollan told ISRAEL21c when we first wrote about manhood in 2017.

“Also, premature ejaculation is a problem that people want to deal with when it occurs, not necessarily with a 24-hour effective solution.”

In this regard, the vPatch is more like a condom than Viagra, Salton says. It is used when necessary and then disposed of afterwards.

And like a condom, the vPatch is intended to be sold without a prescription (OTC) in pharmacies. For now, however, it requires a prescription in the United States. The product will also debut later this year in Israel. Salton says Virility plans to sell vPatches directly to consumers through its website.

Part of the marketing strategy is to “approach couples, not just the man,” Salton adds, “to improve the sexual well-being of both men and women.”

Efrat Riklin, Marketing Director of Virility. Photo courtesy of Virility Medical

“We are planning massive publicity, on social networks, digital channels, television, radio”, explains Efrat Riklin, marketing director of Virility.

Can you buy vPatches in a sex shop? No, said Riklin. “This is not a sex toy or a vibrator. It is an FDA cleared medical device that has been clinically tested and proven. We intend to market it to a general public, to people with family.

Dyserection

The market for premature ejaculation solutions is around $3 billion a year and growing.

Virility Medical is also looking into the erectile dysfunction market.

“Erectile dysfunction is the second most common sexual disorder in men,” says Salton. “A lot of people are being treated with Viagra. But most of these men are using it to improve their performance, not to treat an actual disorder. So we’re looking at that ‘recreational market’ as well.

According to a study conducted by Geocartography for Virility in China, the US, the UK, Germany and Israel, 72% of respondents said the product would be “relevant” to them. “Part of it is recreational,” Salton insists.

The company is already working on a reusable version of the product with a rechargeable battery. The new patch, which won’t be ready for at least a year, will include a Bluetooth-connected app that lets users control the intensity.

The seven-person company has raised a total of $10 million, much of it from Arkin Holdings, and $1 million from the Israel Innovation Authority.

Do Salton, Riklin, and Gollan find they get into, uh, awkward situations when someone asks, “So what do you do for a living?”

“People always tell their kinda embarrassing jokes,” Gollan says, “but who isn’t familiar with this problem?”

There are also advantages.

“I was in a meeting and then someone knocked on my car window,” Salton recalled.

“Do you have a sample you can give me?” asked the man.

“Every time we talk about it over dinner, people are very curious, if they need it or would like to try it. It gets a lot of interest,” Salton says.

Share.

Comments are closed.